Stock AFMD AFFIMED N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Affimed N.V.

Equities

AFMD

NL0015001ZQ0

Market Closed - Nasdaq
Other stock markets
 01:30:00 01/06/2024 am IST 		5-day change 1st Jan Change
4.35 USD +7.14% Intraday chart for Affimed N.V. +3.82% -30.40%
29/05 Affimed Says US FDA Grants Fast-Track Designation for Potential Lung Cancer Therapy MT
29/05 Affimed N.V. Receives Fast Track Designation for Combination Therapy of Afm24 with Atezolizumab for Egfr Wild-Type Non-Small Cell Lung Cancer CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
AFFIMED N.V. Stock Affimed N.V.
 66.24M - - -
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 24.28B -
ARGENX SE Stock argenx SE
 21.96B -
GENMAB A/S Stock Genmab A/S
 18.16B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
 16.37B
  1. Stock Market
  2. Equities
  3. AFMD Stock
  4. Charts Affimed N.V.
  5. Sector Chart